Patents by Inventor Peter Esben Friis

Peter Esben Friis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protease variants and polynucleotides encoding same
    Patent number: 11407989
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: August 9, 2022
    Assignee: Novozymes A/S
    Inventors: Annette H. Johansen, Rolf T. Lenhard, Peter Esben Friis
  • Protease Variants and Polynucleotides Encoding Same
    Publication number: 20170306313
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 29, 2015
    Publication date: October 26, 2017
    Applicant: Novozymes A/S
    Inventors: Annette H. Johansen, Rolf T. Lenhard, Peter Esben Friis
  • METHOD OF PREPARING A DOUGH-BASED PRODUCT
    Publication number: 20100215802
    Abstract: Dough with a high sucrose content (such as cake dough) tends to inhibit the activity of an anti-staling amylase such as Novamyl®, making it less effective to prevent the staling of dough-based products with high sucrose content such as cakes. A good anti-staling effect in cakes can be achieved by using a carefully selected anti-staling amylase with certain properties. Analysis of a 3D structure of Novamyl® shows that sucrose may inhibit by binding in the active site. Sucrose docks into the active site of Novamyl® differently from the substrate or inhibitor in published models 1QHO and 1QHP. This finding is used to design sucrose-tolerant variants.
    Type: Application
    Filed: June 5, 2008
    Publication date: August 26, 2010
    Applicant: Novozymes A/S
    Inventors: Lars Beier, Peter Esben Friis, Henrik Lundqvist, Peter Kamp Hansen, Tina Spendler